Lyubov Aleksandrovna Rzhanova

Dr. Lyubov Aleksandrovna Rzhanova

Regenerative Biology, Koltzov Institute of Developmental Biology Russian Academy of Science, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2024 in Cells
Verified
Journal Article
Open access
PDF file
LRLyubov Aleksandrovna Rzhanova
Lyubov Aleksandrovna Rzhanova
YMYuliya Markitantova
Yuliya Markitantova
MAMaria Aleksandrova
Maria Aleksandrova
Retinal pigment epithelium (RPE) cells are important fundamentally for the development and function of the retina. In this regard, the study of the morphological and molecular properties of RPE cells, as well as their regenerative capabilities, is of particular importance for biomedicine. However, these studies are complicated by the fact that, despite the external morphological similarity of RPE cells, the RPE is a population of heterogeneous cells, the molecular genetic properties of which have begun to be revealed by sequencing methods only in recent years. This review carries out an analysis of the data from morphological and molecular genetic studies of the heterogeneity of RPE cells in mammals and humans, which reveals the individual differences in the subpopulations of RPE cells and the possible specificity of their functions. Particular attention is paid to discussing the properties of “stemness,” proliferation, and plasticity in the RPE, which may be useful for uncovering the mechanisms of retinal diseases associated with pathologies of the RPE and finding new ways of treating them.

1 July 2020 in Russian Journal of Developmental Biology
Verified
Journal Article
Open access
PDF file
LRLyubov Aleksandrovna Rzhanova
Lyubov Aleksandrovna Rzhanova
AKAlla Viktorovna Kuznetsova
Alla Viktorovna Kuznetsova
MAM. A. Aleksandrova
M. A. Aleksandrova
Impairment of the homeostatic and functional integrity of the retina and retinal pigment epithelium (RPE) is the main cause of some degenerative diseases of the human eye, which are accompanied by loss of eyesight. Despite the significant progress made over the past decades in the development of new methods for treatment for this pathology, there are still several complications when using surgical methods for correction of eyesight and so far insurmountable limitations in the applications of modern approaches, such as gene therapy and genetic engineering. One of the promising approaches to the treatment of degenerative diseases of the retina may be an approach based on the application of regenerative capacities of its endogenous cells with high plasticity, in particular, of RPE cells and Müller glia. Currently, vertebrate RPE cells are of great interest as a source of new photoreceptors and other neurons in the degrading retina in vivo . In this regard, the possibilities of their direct reprogramming by genetic, epigenetic, and chemical methods and their combination are being investigated. This review focuses on research in gene-directed reprogramming of vertebrate RPE cells into retinal neurons, with detailed analysis of the genes used as the main reprogramming factors, comparative analysis, and extrapolation of experimental data from animals to humans. Also, this review covers studies on the application of alternative approaches to gene-directed reprogramming, such as chemical-mediated reprogramming with the use of cocktails of therapeutic low-molecular-weight compounds and microRNAs. In general, the research results indicate the complexity of the process for direct reprogramming of human RPE cells into retinal neurons. However, taking into account the results of direct reprogramming of vertebrate cells and the accessibility of human RPE cells for various vectors that deliver a variety of molecules to cells, such as transcription factors, chimeric endonucleases, recombinant proteins, and low-weight molecular compounds, the most optimal combination of factors for the successful conversion of human RPE cells to retinal neurons can be suggested.

1 March 2019 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
AKAlla Viktorovna Kuznetsova
Alla Viktorovna Kuznetsova
AKA. M. Kurinov
A. M. Kurinov
LRLyubov Aleksandrovna Rzhanova
Lyubov Aleksandrovna Rzhanova
MAMaria Aleksandrova
Maria Aleksandrova
Changes in morphology and molecular genetic profile of human retinal pigment epithelial (RPE) cells in vitro were studied when exposed to the basic fibroblast growth factor (bFGF). The cell...

1 July 2019 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
AKAlla Viktorovna Kuznetsova
Alla Viktorovna Kuznetsova
LRLyubov Aleksandrovna Rzhanova
Lyubov Aleksandrovna Rzhanova
AKA. M. Kurinov
A. M. Kurinov
MAMaria Aleksandrova
Maria Aleksandrova
Retinal pigment epithelium (RPE) plays a key role in the development of many eye diseases characterized by visual impairment and even blindness. The use of cell cultures to model changes in...

1 March 2021 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
ESE. V. Shafei
E. V. Shafei
LRLyubov Aleksandrovna Rzhanova
Lyubov Aleksandrovna Rzhanova
YNY. P. Novikova
Y. P. Novikova
AKA. M. Kurinov
A. M. Kurinov
EGE. N. Grigoryan
E. N. Grigoryan
AKAlla Viktorovna Kuznetsova
Alla Viktorovna Kuznetsova
The development of the retina and the signaling pathways involved in this process are conserved among vertebrates. Therefore, it was hypothesized that active factors stimulating the retinal regeneration in newts can cause transdifferentiation of human retinal pigment epithelial (RPE) cells. To verify this, we studied the effect of conditioned media (CM) obtained from in vitro regenerating retinas of newts on the phenotype, expression of a number of genes, and localization of cell proteins of human RPE cells of the ARPE-19 line. Within 120 h of cultivation, a change in the morphology of human RPE cells was observed, which manifested in a change in shape and an increase in cell size, which was accompanied by a decrease in proliferative activity. 24 hours after exposure to CM, ARPE-19 showed a short-term increase in the expression of TUBB3 (a panneuronal marker) and a decrease in the expression of BMP2 and BMP4 (neural diffe-rentiation inhibitors). Using immunocytochemical (ICC) methods, we observed an increase in the intensity of staining of cells with antibodies to βIII-tubulin protein and a decrease in the intensity of staining with antibodies to the Cx43 protein of gap junctions (compared to the control) during the period between 24 and 72 h after exposure. At the same time, we observed a decrease in the levels of mRNA expression of the RPE markers OTX2 and KRT18, as well as the KLF4 gene, which is responsible for proliferation and differentiation. Additionally, the shift in the distribution of β-catenin to cytoplasmic localization was recorded using the ICC method. To exclude mesenchymal (and osteogenic in particular) differentiation under the effect of CM, we studied expression of the SPP1 and RUNX2 genes by qPCR. No SPP1 transcription was found in ARPE-19 cells in the control and under the effect of CM, and a decrease in the expression level of RUNX2 mRNA under the effect of CM was observed. Therefore, an attempt to shift to neuronal differentiation was observed in ARPE-19 cells during the period between 24 and 72 h after exposure to the CM of newt retinal regenerates, as indicated by an increase in transcription and translation of βIII-tubulin, a weakening of intercellular adhesion, and a decrease in the expression of inhibitors of neural differentiation BMP2 and BMP4, as well as RPE markers OTX2 and KRT18. However, after that, due to the short-term effect of CM, during the period between 72 and 120 h after exposure, the cells returned to the initial differentiation, as evidenced by a decrease in the expression of neuronal differentiation markers (NES, TUBB3, PAX6) and an increase in the expression of RPE markers (OTX2, MITF).

17 November 2025 in Cells
Verified
Journal Article
Open access
PDF file
ARAndrei Riabinin
Andrei Riabinin
DZDmitry D. Zhdanov
Dmitry D. Zhdanov
VBVarvara Blinova
Varvara Blinova
APAlena Permyakova
Alena Permyakova
ASAlina A. Stulova
Alina A. Stulova
EVEkaterina A. Vorotelyak
Ekaterina A. Vorotelyak
The adoptive transfer of Tregs is a promising immunotherapeutic strategy for type 1 diabetes mellitus (T1D). A key focus in this field is the creation of antigen-specific CAR-Tregs targeted against pancreatic islet antigens. However, the efficacy of such therapies is potentially limited by the instability of the Treg phenotype in the inflammatory conditions of T1D. This review discusses molecular approaches to overcome this limitation. These include the genetic engineering of cytokine signaling pathways (IL2, IL33/ST2, and IL35) and the cAMP cascade, the management of FOXP3 splicing to ensure stable expression of concrete splice variants, and the use of epigenetic mechanisms to promote a durable Treg identity.